Guillain‐Barré syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506 | Zendy

Moon JoonShik | Zendy; Souayah Nizar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Guillain‐Barré syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506

Author(s) -

Moon JoonShik,

Souayah Nizar

Publication year - 2006

Publication title -

liver transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.814

H-Index - 150

eISSN - 1527-6473

pISSN - 1527-6465

DOI - 10.1002/lt.20864

Subject(s) - medicine , liver transplantation , tacrolimus , guillain barre syndrome , complication , immunology , vaccination , liver dysfunction , antibody , transplantation , gastroenterology

Guillain‐Barré syndrome (GBS) has been rarely reported after liver transplantation and generally has good outcome. We report a liver transplant patient on FK506 (tacrolimus) who developed GBS 6 months after liver transplantation. There was no evidence of liver rejection or active infection. Despite treatment with intravenous immunoglobulin, the patient expired. GBS occurred despite downregulation of T cells by FK506, suggesting that humoral dysfunction might be the predominant mechanism of GBS in this report. Liver Transpl 12:1537–1539, 2006. © 2006 AASLD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research